| 501 | PROKProkidney Corp. |
$893K |
-7,725.2% |
2025 |
| 502 | HWHHWH International Inc. |
$866.9K |
-303.4% |
2025 |
| 503 | RLYBRallybio Corp |
$858K |
-1,046.4% |
2025 |
| 504 | HYPDHyperion Defi, Inc. |
$813.5K |
-5,570.6% |
2025 |
| 505 | IMAImageneBio, Inc. |
$800K |
-5,668.6% |
2025 |
| 506 | MCRBSeres Therapeutics, Inc. |
$789K |
721.9% |
2025 |
| 507 | SPAISafe Pro Group Inc. |
$606.7K |
-2,360.8% |
2025 |
| 508 | YDESYD Bio Ltd |
$596.8K |
-1,392.6% |
2025 |
| 509 | CRDFCardiff Oncology, Inc. |
$593K |
-7,732.0% |
2025 |
| 510 | YARWYarrow Bioscience, Inc. |
$570K |
-4,646.1% |
2025 |
| 511 | QUCYQuantum Cyber N.V. |
$537.1K |
-3,018.3% |
2025 |
| 512 | LIPOLipella Pharmaceuticals Inc. |
$536.4K |
-935.2% |
2024 |
| 513 | MREOMereo BioPharma Group plc |
$500K |
-8,375.6% |
2025 |
| 514 | MNOVMedicinova Inc |
$409.7K |
-2,928.8% |
2025 |
| 515 | PLSEPulse Biosciences, Inc. |
$350K |
-20,794.6% |
2025 |
| 516 | QTEXQTREX Quantum Ltd. |
$289K |
-4,574.4% |
2025 |
| 517 | COCHEnvoy Medical, Inc. |
$241K |
-9,857.3% |
2025 |
| 518 | SKYASkyAI, Inc. |
$204.1K |
-138,400.0% |
2025 |
| 519 | CLNNClene Inc. |
$200K |
-13,086.5% |
2025 |
| 520 | ATYRaTYR PHARMA INC |
$190K |
-39,009.5% |
2025 |
| 521 | SERSerina Therapeutics, Inc. |
$130K |
-14,755.4% |
2025 |
| 522 | AGPUAxe Compute Inc. |
$125.3K |
-186,053.4% |
2025 |
| 523 | IBIOiBio, Inc. |
$100K |
-33,044.0% |
2026 |
| 524 | SERASera Prognostics, Inc. |
$81K |
-39,417.3% |
2025 |
| 525 | PAVMPAVmed Inc. |
$71K |
564.8% |
2025 |
| 526 | INOInovio Pharmaceuticals, Inc. |
$65.3K |
-130,000.0% |
2025 |
| 527 | CNTBConnect Biopharma Holdings Ltd |
$64K |
-86,687.5% |
2025 |
| 528 | AVTXAvalo Therapeutics, Inc. |
$59K |
-132,642.4% |
2025 |
| 529 | INMBInmune Bio, Inc. |
$50K |
-91,866.0% |
2025 |
| 530 | ENTXEntera Bio Ltd. |
$42K |
-27,235.7% |
2025 |
| 531 | KZIAKazia Therapeutics Ltd |
A$42K |
-49,290.5% |
2025 |
| 532 | ALTAltimmune, Inc. |
$41K |
-214,861.0% |
2025 |
| 533 | NTHINeonc Technologies Holdings, Inc. |
$40K |
-155,404.4% |
2025 |
| 534 | LYELLyell Immunopharma, Inc. |
$36K |
-762,355.6% |
2025 |
| 535 | IBOImpact Biomedical Inc. |
$32K |
-36,993.8% |
2025 |
| 536 | IFRXInflaRx N.V. |
€29.3K |
-155,582.1% |
2025 |
| 537 | TLPHTalphera, Inc. |
$28K |
-51,035.7% |
2025 |
| 538 | GNLXGENELUX Corp |
$8K |
-401,812.5% |
2025 |
| 539 | RVMDRevolution Medicines, Inc. |
$0 |
n/a |
2025 |
| 540 | PRAXPraxis Precision Medicines, Inc. |
$0 |
n/a |
2025 |
| 541 | SYRESpyre Therapeutics, Inc. |
$0 |
n/a |
2025 |
| 542 | SRRKScholar Rock Holding Corp |
$0 |
n/a |
2025 |
| 543 | VKTXViking Therapeutics, Inc. |
$0 |
n/a |
2025 |
| 544 | DNLIDenali Therapeutics Inc. |
$0 |
n/a |
2025 |
| 545 | AMLXAmylyx Pharmaceuticals, Inc. |
$0 |
n/a |
2025 |
| 546 | DSGNDesign Therapeutics, Inc. |
$0 |
n/a |
2025 |
| 547 | MNPRMonopar Therapeutics |
$0 |
n/a |
2025 |
| 548 | NGNENeurogene Inc. |
$0 |
n/a |
2025 |
| 549 | ALLOAllogene Therapeutics, Inc. |
$0 |
n/a |
2025 |
| 550 | ARTVArtiva Biotherapeutics, Inc. |
$0 |
n/a |
2025 |